MedPath

Chengdu Suncadia Medicine Co., Ltd.

🇨🇳China
Ownership
-
Established
1958-01-01
Employees
-
Market Cap
-
Website
http://cac.avic.com

Study of HRS-5965 in Healthy Subjects and Subjects With Renal Insufficiency

Phase 1
Completed
Conditions
Glomerulonephritis
Interventions
Drug: Placebo
First Posted Date
2022-08-18
Last Posted Date
2024-10-23
Lead Sponsor
Chengdu Suncadia Medicine Co., Ltd.
Target Recruit Count
83
Registration Number
NCT05505955
Locations
🇨🇳

The Affiliated hospital of QingDao University, Qingdao, Shandong, China

A Study to Assess the Efficacy and Safety of Paricalcitol in the Treatment of Chronic Kidney Disease With Secondary Hyperparathyroidism

Phase 3
Conditions
Secondary Hyperparathyroidism
Interventions
Drug: Placebo
First Posted Date
2021-08-06
Last Posted Date
2022-02-10
Lead Sponsor
Chengdu Suncadia Medicine Co., Ltd.
Target Recruit Count
84
Registration Number
NCT04994080
© Copyright 2025. All Rights Reserved by MedPath